PRVCF Projected Dividend Yield
PreveCeutical Medical Inc ( OTCBB : PRVCF )Preveceutical Medical is engaged in the business of licensing, branding and marketing of nutraceutical and wellness products. Co. has one product available for sale, the CELLB9™ immune-system booster. CELLB9™ is an oral solution containing polarized and potentiated essential minerals extracted from a novel peptide, obtained from blue scorpion serum. The active potentiated ingredients in the blue scorpion serum appear to support health at a deep cellular level, having been used for many years and in over 40 countries. The solution is colorless and odorless and can be administered orally. CELLB9™ is produced by Samson Pharmaceuticals Inc., in its FDA approved facility in the U.S. 21 YEAR PERFORMANCE RESULTS |
PRVCF Dividend History Detail PRVCF Dividend News PRVCF Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |